Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ) is now available.
Shanghai Bio-Heart Biological Technology Co., Ltd. has announced an extraordinary general meeting scheduled for February 13, 2025, to discuss several key resolutions. The meeting will address amendments to the company’s business scope, the approval of investment and shareholders agreements, and proposed changes to the articles of association, reflecting a strategic focus on growth and operational enhancement.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-Heart Biological Technology Co., Ltd. is a company based in the People’s Republic of China, specializing in biological technology. It is listed on the Stock Exchange of Hong Kong and operates within the high-tech sector, focusing on innovative solutions in the biotechnology industry.
YTD Price Performance: -8.54%
Average Trading Volume: 26,992
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$627.8M
See more data about 2185 stock on TipRanks’ Stock Analysis page.
